SEC Form 4 · accession 0001192482-18-000474
Aevi Genomic Medicine, Inc. · GNMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph J Grano Jr.
Director
Period of report
Nov 7, 2018
Accepted (ET)
Nov 13, 2018 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001138776
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 7, 2018 | P | 26,000 | $1.162 | A | 75,683 | D | |
| Common StockF3 | Nov 7, 2018 | P | 21,000 | $1.17 | A | 27,000 | I | By wife |
| Common StockF4 | Nov 7, 2018 | P | 21,000 | $1.15 | A | 56,780 | I | By The Grano Children's Trust Robert Silver and Joseph C Grano Trustees |
| Common Stock | holding | — | — | — | 15,384 | I | By The Grano Family Foundation |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $1.15 to $1.17, inclusive. The reporting person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F2Total amount revised to reflect 7,000 shares of common stock incorrectly reported as owned by the reporting person.
- F3Includes 6,000 shares of common stock previously reported as held directly by the reporting person.
- F4Includes 35,780 shares of common stock previously reported as held directly by the reporting person.